nodes	percent_of_prediction	percent_of_DWPC	metapath
Acepromazine—ALB—lung cancer	0.557	1	CbGaD
Acepromazine—ALB—Gefitinib—lung cancer	0.11	0.415	CbGbCtD
Acepromazine—ALB—Erlotinib—lung cancer	0.0648	0.246	CbGbCtD
Acepromazine—ALB—Irinotecan—lung cancer	0.0585	0.222	CbGbCtD
Acepromazine—ALB—Methotrexate—lung cancer	0.031	0.117	CbGbCtD
Acepromazine—HTR2A—phrenic nerve—lung cancer	0.0131	0.501	CbGeAlD
Acepromazine—HTR2A—pulmonary artery—lung cancer	0.00476	0.182	CbGeAlD
Acepromazine—ALB—mammary gland—lung cancer	0.00234	0.0893	CbGeAlD
Acepromazine—DRD2—respiratory system—lung cancer	0.00121	0.0464	CbGeAlD
Acepromazine—ADRA1A—epithelium—lung cancer	0.00103	0.0396	CbGeAlD
Acepromazine—HTR2A—respiratory system—lung cancer	0.0008	0.0306	CbGeAlD
Acepromazine—HTR2A—epithelium—lung cancer	0.000669	0.0256	CbGeAlD
Acepromazine—Clomipramine—GSTP1—lung cancer	0.000661	0.115	CrCbGaD
Acepromazine—DRD2—lung—lung cancer	0.000644	0.0246	CbGeAlD
Acepromazine—HTR2A—trachea—lung cancer	0.000591	0.0226	CbGeAlD
Acepromazine—ALB—lymph node—lung cancer	0.000565	0.0216	CbGeAlD
Acepromazine—HTR2A—lung—lung cancer	0.000425	0.0163	CbGeAlD
Acepromazine—Desipramine—CYP2A6—lung cancer	0.000384	0.0668	CrCbGaD
Acepromazine—Fluphenazine—CYP2E1—lung cancer	0.000371	0.0645	CrCbGaD
Acepromazine—Thioridazine—CYP2E1—lung cancer	0.00032	0.0555	CrCbGaD
Acepromazine—Methotrimeprazine—CYP2E1—lung cancer	0.000305	0.053	CrCbGaD
Acepromazine—Diltiazem—ABCB1—lung cancer	0.000284	0.0493	CrCbGaD
Acepromazine—Desipramine—CYP2E1—lung cancer	0.000273	0.0474	CrCbGaD
Acepromazine—Triflupromazine—ABCB1—lung cancer	0.000253	0.044	CrCbGaD
Acepromazine—Thioproperazine—ALB—lung cancer	0.00024	0.0417	CrCbGaD
Acepromazine—Thiothixene—ALB—lung cancer	0.000236	0.041	CrCbGaD
Acepromazine—Pipotiazine—ALB—lung cancer	0.000236	0.041	CrCbGaD
Acepromazine—Chlorpromazine—CYP2E1—lung cancer	0.000233	0.0404	CrCbGaD
Acepromazine—Imipramine—CYP2E1—lung cancer	0.000231	0.0402	CrCbGaD
Acepromazine—Fluphenazine—ABCB1—lung cancer	0.000194	0.0338	CrCbGaD
Acepromazine—Clomipramine—ALB—lung cancer	0.000186	0.0324	CrCbGaD
Acepromazine—Clomipramine—ABCB1—lung cancer	0.000178	0.0309	CrCbGaD
Acepromazine—Chlorprothixene—ABCB1—lung cancer	0.000177	0.0308	CrCbGaD
Acepromazine—Trimipramine—ABCB1—lung cancer	0.000164	0.0284	CrCbGaD
Acepromazine—Promethazine—ABCB1—lung cancer	0.000158	0.0274	CrCbGaD
Acepromazine—Trifluoperazine—ABCB1—lung cancer	0.000155	0.027	CrCbGaD
Acepromazine—Desipramine—ABCB1—lung cancer	0.000143	0.0249	CrCbGaD
Acepromazine—Chlorpromazine—ALB—lung cancer	0.000128	0.0222	CrCbGaD
Acepromazine—Chlorpromazine—ABCB1—lung cancer	0.000122	0.0212	CrCbGaD
Acepromazine—Imipramine—ABCB1—lung cancer	0.000121	0.0211	CrCbGaD
Acepromazine—HTR2A—Signaling by GPCR—NRAS—lung cancer	1.63e-05	0.000111	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—KRAS—lung cancer	1.62e-05	0.00011	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CXCL8—lung cancer	1.61e-05	0.00011	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—PIK3CA—lung cancer	1.61e-05	0.000109	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—EGF—lung cancer	1.61e-05	0.000109	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—HRAS—lung cancer	1.6e-05	0.000109	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PIK3CB—lung cancer	1.6e-05	0.000109	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PIK3CG—lung cancer	1.6e-05	0.000108	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—APC—lung cancer	1.6e-05	0.000108	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—KIT—lung cancer	1.6e-05	0.000108	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—NRAS—lung cancer	1.6e-05	0.000108	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MAP2K1—lung cancer	1.59e-05	0.000108	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PTGS2—lung cancer	1.59e-05	0.000108	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—MAPK3—lung cancer	1.59e-05	0.000108	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PIK3CD—lung cancer	1.58e-05	0.000107	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—EGF—lung cancer	1.58e-05	0.000107	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—POMC—lung cancer	1.58e-05	0.000107	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—PIK3CA—lung cancer	1.56e-05	0.000106	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—MAPK3—lung cancer	1.56e-05	0.000106	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—AKT1—lung cancer	1.56e-05	0.000106	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—TP53—lung cancer	1.56e-05	0.000106	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—BRAF—lung cancer	1.56e-05	0.000106	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—POMC—lung cancer	1.55e-05	0.000105	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—KRAS—lung cancer	1.55e-05	0.000105	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CASP3—lung cancer	1.55e-05	0.000105	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IL2—lung cancer	1.54e-05	0.000105	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IL6R—lung cancer	1.54e-05	0.000104	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—IL6—lung cancer	1.54e-05	0.000104	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CREBBP—lung cancer	1.54e-05	0.000104	CbGpPWpGaD
Acepromazine—ALB—Metabolism—APOA1—lung cancer	1.53e-05	0.000104	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—BRAF—lung cancer	1.53e-05	0.000104	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—MAPK3—lung cancer	1.53e-05	0.000104	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—POMC—lung cancer	1.52e-05	0.000103	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IL6R—lung cancer	1.51e-05	0.000103	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CREBBP—lung cancer	1.51e-05	0.000103	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—EGFR—lung cancer	1.51e-05	0.000102	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CCND1—lung cancer	1.5e-05	0.000102	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—JUN—lung cancer	1.5e-05	0.000102	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—BRAF—lung cancer	1.5e-05	0.000102	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—PIK3CA—lung cancer	1.49e-05	0.000101	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—HRAS—lung cancer	1.49e-05	0.000101	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MDM2—lung cancer	1.49e-05	0.000101	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—EGFR—lung cancer	1.48e-05	0.000101	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IL6R—lung cancer	1.48e-05	0.000101	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—RAF1—lung cancer	1.48e-05	0.000101	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CREBBP—lung cancer	1.48e-05	0.0001	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.47e-05	9.97e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MAP2K1—lung cancer	1.47e-05	9.95e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—ERBB2—lung cancer	1.46e-05	9.95e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—MMP9—lung cancer	1.46e-05	9.92e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PIK3CD—lung cancer	1.46e-05	9.89e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CDKN1A—lung cancer	1.46e-05	9.89e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—EGFR—lung cancer	1.45e-05	9.87e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—PTEN—lung cancer	1.45e-05	9.86e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PIK3CB—lung cancer	1.45e-05	9.82e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MTOR—lung cancer	1.45e-05	9.82e-05	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—PIK3CA—lung cancer	1.44e-05	9.79e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MAP2K1—lung cancer	1.44e-05	9.79e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PIK3CD—lung cancer	1.43e-05	9.73e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—KRAS—lung cancer	1.43e-05	9.68e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—PIK3CA—lung cancer	1.42e-05	9.65e-05	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—PIK3CA—lung cancer	1.42e-05	9.64e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—AKT1—lung cancer	1.42e-05	9.62e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MDM2—lung cancer	1.41e-05	9.61e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MAP2K1—lung cancer	1.41e-05	9.59e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—RAF1—lung cancer	1.41e-05	9.58e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PIK3CD—lung cancer	1.4e-05	9.53e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—KRAS—lung cancer	1.4e-05	9.53e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PIK3CG—lung cancer	1.4e-05	9.5e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—ERBB2—lung cancer	1.39e-05	9.47e-05	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—PIK3CA—lung cancer	1.39e-05	9.44e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CXCL8—lung cancer	1.39e-05	9.43e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—EP300—lung cancer	1.38e-05	9.41e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PTEN—lung cancer	1.38e-05	9.41e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—HRAS—lung cancer	1.38e-05	9.37e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PIK3CB—lung cancer	1.38e-05	9.35e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MTOR—lung cancer	1.38e-05	9.35e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—KRAS—lung cancer	1.37e-05	9.33e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—SRC—lung cancer	1.35e-05	9.15e-05	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—AKT1—lung cancer	1.34e-05	9.11e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—POMC—lung cancer	1.33e-05	9.05e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CASP3—lung cancer	1.33e-05	9.03e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IL2—lung cancer	1.33e-05	9.02e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CXCL8—lung cancer	1.32e-05	8.98e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—EP300—lung cancer	1.32e-05	8.97e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—IL6—lung cancer	1.32e-05	8.97e-05	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—AKT1—lung cancer	1.32e-05	8.94e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—HRAS—lung cancer	1.31e-05	8.93e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—VEGFA—lung cancer	1.31e-05	8.91e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—PIK3CA—lung cancer	1.31e-05	8.89e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MDM2—lung cancer	1.3e-05	8.86e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—RAF1—lung cancer	1.3e-05	8.83e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—STAT3—lung cancer	1.3e-05	8.82e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CREBBP—lung cancer	1.3e-05	8.81e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—NRAS—lung cancer	1.3e-05	8.8e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCND1—lung cancer	1.29e-05	8.79e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—JUN—lung cancer	1.29e-05	8.77e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—PIK3CA—lung cancer	1.29e-05	8.75e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—ERBB2—lung cancer	1.29e-05	8.73e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MDM2—lung cancer	1.28e-05	8.72e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—RAF1—lung cancer	1.28e-05	8.69e-05	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—AKT1—lung cancer	1.28e-05	8.68e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MTOR—lung cancer	1.27e-05	8.62e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PIK3CB—lung cancer	1.27e-05	8.62e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CASP3—lung cancer	1.27e-05	8.6e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—ERBB2—lung cancer	1.26e-05	8.59e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IL2—lung cancer	1.26e-05	8.59e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	1.26e-05	8.57e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—IL6—lung cancer	1.26e-05	8.54e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MDM2—lung cancer	1.26e-05	8.53e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MMP9—lung cancer	1.26e-05	8.53e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—RAF1—lung cancer	1.25e-05	8.5e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CDKN1A—lung cancer	1.25e-05	8.5e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PTEN—lung cancer	1.25e-05	8.48e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PIK3CB—lung cancer	1.25e-05	8.48e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MTOR—lung cancer	1.25e-05	8.48e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—MAPK3—lung cancer	1.24e-05	8.43e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—ERBB2—lung cancer	1.24e-05	8.41e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCND1—lung cancer	1.23e-05	8.37e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PIK3CD—lung cancer	1.23e-05	8.35e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—JUN—lung cancer	1.23e-05	8.35e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MTOR—lung cancer	1.22e-05	8.3e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	1.22e-05	8.3e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CXCL8—lung cancer	1.22e-05	8.28e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—AKT1—lung cancer	1.22e-05	8.28e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—HRAS—lung cancer	1.21e-05	8.23e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—MYC—lung cancer	1.21e-05	8.2e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CXCL8—lung cancer	1.2e-05	8.15e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MMP9—lung cancer	1.2e-05	8.13e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—HRAS—lung cancer	1.19e-05	8.1e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CDKN1A—lung cancer	1.19e-05	8.1e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—EP300—lung cancer	1.19e-05	8.09e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PTEN—lung cancer	1.19e-05	8.08e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—EGFR—lung cancer	1.18e-05	8.02e-05	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—AKT1—lung cancer	1.18e-05	8e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CXCL8—lung cancer	1.17e-05	7.98e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—HRAS—lung cancer	1.17e-05	7.93e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CASP3—lung cancer	1.17e-05	7.93e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IL2—lung cancer	1.17e-05	7.92e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—AKT1—lung cancer	1.16e-05	7.88e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—IL6—lung cancer	1.16e-05	7.88e-05	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—AKT1—lung cancer	1.16e-05	7.87e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—SRC—lung cancer	1.16e-05	7.87e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CASP3—lung cancer	1.15e-05	7.8e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IL2—lung cancer	1.15e-05	7.79e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—IL6—lung cancer	1.14e-05	7.75e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCND1—lung cancer	1.14e-05	7.72e-05	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	1.13e-05	7.71e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—EP300—lung cancer	1.13e-05	7.7e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—JUN—lung cancer	1.13e-05	7.7e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—VEGFA—lung cancer	1.13e-05	7.66e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CASP3—lung cancer	1.12e-05	7.64e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IL2—lung cancer	1.12e-05	7.63e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCND1—lung cancer	1.12e-05	7.59e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—IL6—lung cancer	1.12e-05	7.59e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—STAT3—lung cancer	1.12e-05	7.59e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—JUN—lung cancer	1.12e-05	7.58e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—KRAS—lung cancer	1.11e-05	7.57e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—NRAS—lung cancer	1.11e-05	7.57e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—SRC—lung cancer	1.1e-05	7.49e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MMP9—lung cancer	1.1e-05	7.49e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CDKN1A—lung cancer	1.1e-05	7.46e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PTEN—lung cancer	1.1e-05	7.45e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCND1—lung cancer	1.09e-05	7.43e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—JUN—lung cancer	1.09e-05	7.42e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MMP9—lung cancer	1.09e-05	7.37e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CDKN1A—lung cancer	1.08e-05	7.34e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PTEN—lung cancer	1.08e-05	7.33e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—VEGFA—lung cancer	1.07e-05	7.3e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PIK3CB—lung cancer	1.07e-05	7.28e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—AKT1—lung cancer	1.07e-05	7.27e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MAPK3—lung cancer	1.07e-05	7.25e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—STAT3—lung cancer	1.06e-05	7.22e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MMP9—lung cancer	1.06e-05	7.22e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PTGS2—lung cancer	1.06e-05	7.22e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—NRAS—lung cancer	1.06e-05	7.21e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	1.06e-05	7.19e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PTEN—lung cancer	1.06e-05	7.18e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—AKT1—lung cancer	1.05e-05	7.15e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—EP300—lung cancer	1.05e-05	7.1e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MYC—lung cancer	1.04e-05	7.05e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	1.03e-05	7e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—EP300—lung cancer	1.03e-05	6.99e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—PIK3CA—lung cancer	1.02e-05	6.96e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—SRC—lung cancer	1.02e-05	6.91e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	1.02e-05	6.9e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—EGFR—lung cancer	1.01e-05	6.89e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—EP300—lung cancer	1.01e-05	6.84e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—SRC—lung cancer	1e-05	6.8e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—TP53—lung cancer	9.91e-06	6.73e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—VEGFA—lung cancer	9.9e-06	6.73e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MYC—lung cancer	9.88e-06	6.71e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—STAT3—lung cancer	9.8e-06	6.66e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—SRC—lung cancer	9.8e-06	6.65e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—NRAS—lung cancer	9.78e-06	6.64e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PIK3CA—lung cancer	9.77e-06	6.64e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—VEGFA—lung cancer	9.74e-06	6.62e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—EGFR—lung cancer	9.67e-06	6.57e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—STAT3—lung cancer	9.65e-06	6.55e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—NRAS—lung cancer	9.62e-06	6.54e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—KRAS—lung cancer	9.59e-06	6.51e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	9.54e-06	6.48e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—HRAS—lung cancer	9.48e-06	6.44e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—STAT3—lung cancer	9.45e-06	6.42e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—NRAS—lung cancer	9.42e-06	6.4e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MAPK3—lung cancer	9.37e-06	6.36e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PTEN—lung cancer	9.26e-06	6.29e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MAPK3—lung cancer	9.22e-06	6.26e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—KRAS—lung cancer	9.13e-06	6.2e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MYC—lung cancer	9.11e-06	6.19e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IL6—lung cancer	9.07e-06	6.16e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	9.02e-06	6.13e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MYC—lung cancer	8.96e-06	6.09e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—EGFR—lung cancer	8.91e-06	6.05e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—EP300—lung cancer	8.83e-06	6e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PIK3CA—lung cancer	8.81e-06	5.98e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MYC—lung cancer	8.78e-06	5.96e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—EGFR—lung cancer	8.77e-06	5.96e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—EGFR—lung cancer	8.59e-06	5.83e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—TP53—lung cancer	8.52e-06	5.79e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—KRAS—lung cancer	8.42e-06	5.72e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	8.39e-06	5.7e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—AKT1—lung cancer	8.37e-06	5.68e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—KRAS—lung cancer	8.28e-06	5.63e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—HRAS—lung cancer	8.15e-06	5.54e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—TP53—lung cancer	8.12e-06	5.51e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—KRAS—lung cancer	8.11e-06	5.51e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—AKT1—lung cancer	7.98e-06	5.42e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IL6—lung cancer	7.8e-06	5.3e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—HRAS—lung cancer	7.76e-06	5.27e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PIK3CA—lung cancer	7.73e-06	5.25e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PIK3CA—lung cancer	7.61e-06	5.17e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TP53—lung cancer	7.48e-06	5.08e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	7.45e-06	5.06e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IL6—lung cancer	7.43e-06	5.05e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TP53—lung cancer	7.36e-06	5e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TP53—lung cancer	7.21e-06	4.9e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—AKT1—lung cancer	7.2e-06	4.89e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—HRAS—lung cancer	7.16e-06	4.86e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—HRAS—lung cancer	7.04e-06	4.78e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—HRAS—lung cancer	6.89e-06	4.68e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—AKT1—lung cancer	6.85e-06	4.66e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IL6—lung cancer	6.85e-06	4.65e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IL6—lung cancer	6.74e-06	4.58e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IL6—lung cancer	6.6e-06	4.48e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PIK3CA—lung cancer	6.53e-06	4.44e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—AKT1—lung cancer	6.32e-06	4.29e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—AKT1—lung cancer	6.22e-06	4.22e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—AKT1—lung cancer	6.09e-06	4.14e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—AKT1—lung cancer	5.34e-06	3.63e-05	CbGpPWpGaD
